Results 241 to 250 of about 12,578,048 (280)

Low‐molecular‐weight heparins and angiogenesis

APMIS, 2006
The involvement of the vascular system in malignancy encompasses not only angiogenesis, but also systemic hypercoagulability and a pro‐thrombotic state, and there is increasing evidence that pathways of blood coagulation and angiogenesis are reciprocally linked.
openaire   +2 more sources

Low molecular weight heparin and atherosclerosis

Current Atherosclerosis Reports, 2004
Low molecular weight heparin (LMWH) has dramatically impacted the treatment of venous thromboembolic disease and acute coronary syndromes. Recent studies help define the role of these agents for patients undergoing percutaneous coronary interventions and for patients treated with thrombolytic agents for ST-segment elevation myocardial infarction ...
openaire   +2 more sources

Low Molecular Weight Heparin

Thrombosis and Haemostasis, 1993
openaire   +2 more sources

Heparin/Low-molecular-weight-heparins

Reactions Weekly
  +6 more sources

Heparin and Low-Molecular-Weight Heparin

Chest, 2004
Jack Hirsh, Robert Raschke
openaire   +2 more sources

Heparin/low-molecular-weight-heparins

Reactions Weekly, 2023
openaire   +1 more source

Heparin/low molecular weight heparins

Reactions Weekly, 2008
  +4 more sources

Heparin/low molecular weight heparins

Reactions Weekly, 2020
openaire   +1 more source

Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin

Circulation, 2004
Marc Rodger, M J Kovacs, D R Anderson
exaly  

HEPARIN, LOW MOLECULAR WEIGHT HEPARIN, AND HEPARIN ANALOGUES

British Journal of Haematology, 1984
openaire   +2 more sources